Study of reducing alcohol use with the HA35 supplement
Treatments studied
This early-phase study tests HA35 in people who currently drink less alcohol than typical weekly drinking limits. It aims to see whether the supplement is safe and whether it affects the body in people who are not heavy drinkers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You drink less than 7 drinks per week if you’re a woman, or less than 14 per week if you’re a man
- You can understand the study and sign written consent
- You do not have serious long-term (chronic) illnesses such as cancer (except non-melanoma skin cancer)
- Your diabetes, thyroid, blood pressure, cholesterol, kidneys, and liver must be controlled or normal
- You have no history of alcohol use disorder and are not currently pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study is testing a treatment approach for people with alcoholic hepatitis (liver inflammation caused by heavy alcohol use). It may help by improving liver function and outcomes in people who meet specific lab and health criteria.
This trial tests whether N-acetylcysteine (a supplement-like medicine) can help people with alcohol use disorder reduce or stop drinking. You may be randomly assigned to receive N-acetylcysteine or a comparison treatment, and you’ll complete interviews during the study.
This trial tests a natural supplement blend to see if it can reduce blood alcohol levels faster after drinking. If you are a social drinker, you may be able to join and help find a way to help people sober up more quickly.
This study tests whether reducing alcohol intake can help lower blood pressure and reduce heart risks in adults who drink above recommended limits. Participants will receive support to cut back on drinking and will be monitored for changes in blood pressure and heart health.
This study tests a new oral medication called AFA-281 in healthy people who drink alcohol regularly. The goal is to see how alcohol interacts with the drug and to check its safety.
This trial tests a daily drink with hyaluronic acid (a natural joint lubricant) to see if it can help delay knee pain in people with early osteoarthritis. If you qualify, it might offer a drug-free way to ease your knee discomfort.
Hear when a new Healthy Controls trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.